๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 451 Beijing 25 Shenzhen 23 Zhongshan 17 Nanning 17
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281 Clear sponsor filter
Site location
Guangzhou451 Beijing25 Shenzhen23 Zhongshan17 Nanning17
All 55 locations
Target enrolment
to
490 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
NCT05044117Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University
Phase 3
220
Guangzhou
2021-10-18
Recruiting
Afterload Mismatch Predictive modLE for Transcatheter Edge-to-Edge Repair (AMPLE-TEER)
NCT07019935Mitral Insufficiency
Sun Yat-sen University
Observational
1,000
Guangzhou
2021-10-01
Recruiting
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
NCT04436965Nasopharyngeal Carcinoma, Nutrition Therapy
Sun Yat-sen University
Phase 3
266
Guangzhou
2021-08-16
Recruiting
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
NCT05011487Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2
30
Guangzhou
2021-08-13
Recruiting
Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)
NCT04989621Follicular Lymphoma, Relapsed and Refractory Follicular Lymphoma
Sun Yat-sen University
Phase 2
32
Guangzhou
2021-08-01
Active, closed
PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma
NCT04907370Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
532
Beijing, Chongqing, Foshan, Guangzhou, Nanning, Guiyang, Wuhan, Changsha
2021-08-01
Active, closed
Newly Diagnosed Glioblastoma
NCT04959500Glioblastoma
Sun Yat-sen University
Phase 2
150
Bengbu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Shenzhen, Zhuhai
2021-07-21
Not yet open
An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC
NCT04890522Nasopharyngeal Carcinoma, Metastasis, Chemotherapy, Immunotherapy
Sun Yat-sen University
Phase 2/3
622
Guangzhou
2021-07-01
Recruiting
A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents
NCT07300449Hepatoblastoma
Sun Yat-sen University
Phase 2
100
Guangzhou
2021-06-23
Active, closed
The Effect of Metformin in Patients With Newly Diagnosed mHSPC
NCT04925063Metastatic Prostate Cancer
Sun Yat-sen University
Phase 2
266
Guangzhou
2021-06-16
Active, closed
Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients
NCT04940546Colorectal Cancer Metastatic
Sun Yat-sen University
Phase 1/2
36
Guangzhou
2021-06-16
Active, closed
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
NCT06277388Non-small Cell Lung Cancer, Cardiac Toxicity
Sun Yat-sen University
Observational
231
Guangzhou
2021-06-05
Recruiting
Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma
NCT04944914Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
188
Guangzhou
2021-06-01
Recruiting
Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients
NCT04980716Non-small Cell Lung Cancer, Cardiovascular Complication
Sun Yat-sen University
Phase 3
524
Guangzhou
2021-06-01
Active, closed
Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma
NCT04878458Glaucoma, Angle-Closure
Sun Yat-sen University
Not applicable
124
Guangzhou, Guangdong
2021-05-31
Recruiting
Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma
NCT04859465Angiosarcoma Metastatic
Sun Yat-sen University
Phase 2
69
Guangzhou
2021-05-21
Active, closed
KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
NCT04844619Neovascular Glaucoma, Neovascularization
Sun Yat-sen University
Phase 1
40
Guangzhou
2021-04-19
Recruiting
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
NCT06015802Pituitary Adenoma, Neuroendocrine Tumors
Sun Yat-sen University
Observational
300
Guangzhou
2021-04-01
Recruiting
Topotecan and Melphalan for Retinoblastoma
NCT04799002Retinoblastoma, Chemotherapy Effect
Sun Yat-sen University
Phase 3
50
Guangzhou
2021-03-11
Recruiting
Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma
NCT04778956Nasopharyngeal Carcinoma, PD-1, Surgery
Sun Yat-sen University
Phase 3
218
Guangzhou, Zhongshan, Nanchang
2021-03-03
Recruiting
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
NCT06069232Aortic Valve Disease
Sun Yat-sen University
Observational
2,000
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
2021-03-01
Recruiting
Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)
NCT04777942Hepatocellular Carcinoma
Sun Yat-sen University
Not applicable
320
Guangzhou
2021-02-20
Recruiting
Lymphadenectomy in Early Ovarian Cancer
NCT04710797Ovarian Cancer, Lymphadenectomy
Sun Yat-sen University
Not applicable
656
Guangzhou
2021-01-31
Active, closed
PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer
NCT04833387Colorectal Carcinoma
Sun Yat-sen University
Phase 2
30
Guangzhou
2021-01-01
Recruiting
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
NCT06333561Hepatocellular Carcinoma, Lenvatinib, PD-1 Inhibitor, Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University
Observational
300
Beijing
2021-01-01
Recruiting
Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
NCT07309991Esophageal Carcinoma, Esophageal Adenocarcinoma, Esophagectomy, PaO2
Sun Yat-sen University
Observational
2,500
Guangzhou, Shantou, Shijiazhuang, Shanghai, Chengdu, Nanchong
2021-01-01
Recruiting
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma
NCT06323382Advanced Hepatocellular Carcinoma, Anti-PD1/PDL1 Antibody, Bevacizumab
Sun Yat-sen University
Observational
240
Beijing
2021-01-01
Active, closed
Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma
NCT04562311Bladder Cancer Stage IV
Sun Yat-sen University
Phase 2
45
Guangzhou
2021-01-01
Recruiting
Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC
NCT04615143Recurrent Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2
80
Guangzhou
2020-12-01
Active, closed
Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL
NCT04624958Mantle Cell Lymphoma, Newly-diagnosed Mantle Cell Lymphoma
Sun Yat-sen University
Phase 2
42
Guangzhou
2020-12-01
Recruiting
JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma
NCT05173246Esophageal Small Cell Carcinoma
Sun Yat-sen University
Phase 2
43
Guangzhou
2020-11-17
Recruiting
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
NCT05080010Retinoblastoma
Sun Yat-sen University
Phase 3
500
Guangzhou
2020-11-01
Recruiting
Toripalimab Combined With CAV/IE Regimen
NCT04589741Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2
134
Guangzhou
2020-10-23
Recruiting
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
NCT04453826Nasopharyngeal Cancer, Chemotherapy, Radiotherapy, PD-1 Therapy
Sun Yat-sen University
Phase 3
388
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-09-01
Recruiting
Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)
NCT06524427Non Small Cell Lung Cancer
Sun Yat-sen University
Not applicable
1,124
Chongqing, Lanzhou, Guangzhou, Shenzhen, Guilin, Zhengzhou, Wuhan, Nanjing
2020-08-25
Recruiting
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
NCT04448522Nasopharyngeal Carcinoma, Radiotherapy, Chemotherapy
Sun Yat-sen University
Phase 3
508
Guangzhou, Shaoguan, Zhongshan, Wuzhou
2020-08-18
Active, closed
Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma
NCT04456322Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
381
Guangzhou
2020-08-17
Recruiting
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
NCT04453813Nasopharyngeal Carcinoma, Chemotherapy, Radiotherapy, PD-1 Treatment
Sun Yat-sen University
Phase 3
226
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-07-03
Recruiting
Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma
NCT04425265Surgery, Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Not applicable
500
Guangzhou, Zhuhai, Nanchang
2020-06-30
Recruiting
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
NCT04365036NK/T Cell Lymphoma Nos
Sun Yat-sen University
Phase 3
207
Guangzhou
2020-05-03
Recruiting
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
NCT04544969Circulating Tumor Cell, Nasopharyngeal Carcinoma, Distant Metastases.Clinical, Effects of Chemotherapy
Sun Yat-sen University
Observational
50
Guangzhou
2020-04-01
Active, closed
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
NCT03930498Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
68
Guangzhou
2020-03-12
Recruiting
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
NCT03907826Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
212
Guangzhou, Beijing, Chengdu, Fuzhou, Guiyang, Hangzhou, Nanchang, Nanning
2020-03-01
Active, closed
Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma
NCT04223024Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
246
Guangzhou
2020-01-31
Recruiting
Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
NCT06877416Antibody-drug Conjugates, HER2-low Breast Cancer, Breast Neoplasms
Sun Yat-sen University
Observational
700
Guangzhou
2020-01-01
Recruiting
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT04136886Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
346
Guangzhou
2020-01-01
Active, closed
Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy
NCT04384627Nasopharyngeal Carcinoma, Induction Chemotherapy, Radiotherapy
Sun Yat-sen University
Phase 3
445
Foshan, Zhongshan
2019-12-01
Active, closed
Pd1 Antibody Sintilimab ยฑ Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT04304209Colorectal Cancer Stage II, Colorectal Cancer Stage III
Sun Yat-sen University
Phase 2
195
Guangzhou
2019-10-28
Active, closed
Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
NCT04127227NK/T Cell Lymphoma Nos
Sun Yat-sen University
Phase 2
34
Guangzhou
2019-10-09
Recruiting
mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
NCT04084496Pancreatic Cancer
Sun Yat-sen University
Phase 2
80
Guangzhou
2019-09-01
Active, closed
Myopic Optic Neuropathy in Chinese High Myopia Population
NCT04302220Eye Diseases
Sun Yat-sen University
Observational
813
Guangzhou
2019-06-06
Recruiting
Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer
NCT03926338Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H), Neoadjuvant Therapy
Sun Yat-sen University
Phase 2
270
Guangzhou
2019-05-10
Active, closed
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03840421Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Nasopharyngeal Diseases, Head and Neck Neoplasm
Sun Yat-sen University
Phase 3
468
Guangzhou
2019-04-03
Active, closed
HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC
NCT03869034Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2
40
Guangzhou
2019-03-25
Recruiting
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC
NCT03872661Lung Cancer Stage III
Sun Yat-sen University
Phase 2
36
Guangzhou
2019-03-01
Active, closed
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)
NCT03847857Esophageal Anastomotic Leak
Sun Yat-sen University
Phase 3
360
Guangzhou, Jieyang, Shantou, Zhongshan, Chengdu, Shanghai
2019-02-21
Recruiting
Toripalimab๏ผˆJS001๏ผ‰ as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
NCT03810339Solid Tumor, Advanced Cancer
Sun Yat-sen University
Phase 2
35
Guangzhou, Guiyang, Wuhan, Dalian
2019-01-15
Active, closed
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
NCT04172259Breast Cancer, Neoadjuvant Chemotherapy
Sun Yat-sen University
Phase 2
156
Guangzhou
2019-01-10
Active, closed
TNT to Increase the Clinical Complete Response Rate for Distal LARC
NCT03840239Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III, Chemoradiation
Sun Yat-sen University
Phase 2
98
Guangzhou
2018-12-25
Recruiting
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
NCT03671252Rectal Cancer
Sun Yat-sen University
Phase 3
776
Guangzhou
2018-11-16
Recruiting
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
NCT03561740Breast Cancer
Sun Yat-sen University
Phase 3
794
Guangzhou
2018-07-25
Recruiting
Nanshan Elderly Cohort Study
NCT03569735Hypertension, Type 2 Diabetes Mellitus, Cardiovascular Diseases, Stroke
Sun Yat-sen University
Observational
20,000
Shenzhen, Guangzhou
2018-05-26
Active, closed
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
NCT03493048Colorectal Cancer, Liver Metastases
Sun Yat-sen University
Phase 2
146
Guangzhou
2018-04-15
Recruiting
Shenzhen Birth Cohort Study
NCT03830879Pregnancy Complications, Gestational Diabetes, Obstetric Labor Complications, Neurodevelopmental Disorders
Sun Yat-sen University
Observational
10,000
Shenzhen
2018-03-06
Active, closed
TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma
NCT03306121Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
322
Guangzhou
2017-11-13
Recruiting
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
NCT03353467Nasopharyngeal Carcinoma, Endoscopic Surgery, Primary Napharyngeal Carcinama, Stage I Nasopharyngeal Cancer
Sun Yat-sen University
Not applicable
228
Guangzhou, Zhongshan, Nanning
2017-10-01
Active, closed
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
164
Guangzhou
2017-02-04
Recruiting
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
NCT02954419IgA Nephropathy, Glomerular Diseases
Sun Yat-sen University
Observational
2,000
Guangzhou
2016-11
Recruiting
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
NCT06926959Tricuspid Regurgitation
Sun Yat-sen University
Observational
3,000
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
2016-06-15
Recruiting
MItral Regurgitation Risk Assessment and CLinical modElling
NCT06876883Mitral Insufficiency, Mitral Regurgitation (MR)
Sun Yat-sen University
Observational
2,000
Guangzhou
2016-06-15
Active, closed
Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall
NCT03319758Jaw, Edentulous, Partially, Acquired Absence of Single Tooth
Sun Yat-sen University
Not applicable
15
Guangzhou
2016-05
Recruiting
Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement
NCT02814149Jaw, Edentulous, Partially, Acquired Absence of Single Tooth
Sun Yat-sen University
Not applicable
40
Guangzhou
2016-05
Recruiting
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
NCT02966483Rectal Neoplasms Malignant, Surgery
Sun Yat-sen University
Not applicable
1,114
Beijing, Chongqing, Guangzhou, Zhanjiang, Zunyi, Changsha, Hengyang, Changchun
2016-04
Recruiting
Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
NCT03001934Nephrotic Syndrome
Sun Yat-sen University
Observational
5,000
Guangzhou
2016-04
Recruiting
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
NCT03368651Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3
230
Guangzhou
2016-01-01
Active, closed
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)
NCT02642471Cervical Cancer, Surgery, Quality of Life
Sun Yat-sen University
Not applicable
1,080
Guangzhou
2015-12-31
Active, closed
The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
NCT02460887Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
236
Guangzhou
2015-06
Active, closed
FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)
NCT02572141Colon Cancer
Sun Yat-sen University
Phase 3
738
Guangzhou
2015-01-01
Recruiting
REal-world Data of CARdiometabolic ProtEcTion
NCT07038083Cardiometabolic Diseases
Sun Yat-sen University
Observational
40,000
Guangzhou
2014-01-01
Recruiting
Peritoneal Dialysis Registration System (PERSIST)
NCT02989298ESRD, Disorders Associated With Peritoneal Dialysis
Sun Yat-sen University
Observational
10,000
Guangzhou
2013-12
Recruiting
Wise Practice of Chinese Hemodialysis (WISHES)
NCT03001921Haemolyses and Related Conditions
Sun Yat-sen University
Observational
30,000
Guangzhou
2013-12
Recruiting
High Quality Evidence of Chinese Lupus Nephritis (HELP)
NCT03001973Lupus Nephritis
Sun Yat-sen University
Observational
5,000
Guangzhou
2013-11
Recruiting
Causation And Prognosis Analyses of Coronary Artery Diseases: A Longitudinal Cohort Study
NCT07480512Coronary Artery Disease
Sun Yat-sen University
Observational
30,000
Guangzhou
2013-01-01
Recruiting
Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery
NCT01653223Congenital Heart Disease, Heart Valve Disease
Sun Yat-sen University
Not applicable
369
Guangzhou
2013-01
Recruiting
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
NCT03001947IgA Nephropathy
Sun Yat-sen University
Observational
10,000
Guangzhou
2012-11
Recruiting
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
NCT01994057Non-small Cell Lung Cancer (NSCLC), EGFR-TKI Resistant Mutation, EGFR-TKI Sensitizing Mutation, Germline Mutations
Sun Yat-sen University
Observational
1,000
Guangzhou
2012-09
Recruiting
A Study of 2nd-line FOLFIRI ยฑ Bevacizumab vs. Irinotecan ยฑ Bevacizumab in mCRC
NCT03303495Colorectal Neoplasms, Neoplasm Metastasis, Intestinal Neoplasms, Gastrointestinal Neoplasms
Sun Yat-sen University
Phase 3
280
Guangzhou
2011-11-14
Recruiting
Epstein-Barr Virus and Cancer Risks
NCT06203314Cancer
Sun Yat-sen University
Observational
100,000
Zhongshan, Wuzhou
2008-08-01
Recruiting
The New Serial Treatment of Temporomandibular Disorders
NCT00932594Temporomandibular Disorder
Sun Yat-sen University
Not applicable
4
Guangzhou
2006-01
Recruiting
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
NCT06801977Primary Pulmonary Lymphoepithelioma-like Carcinoma
Sun Yat-sen University
Observational
10,000
Foshan, Guangzhou
2002-01-01
Rows per page Showing 401–490 of 490
Previous 3 4 5
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.